These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29157781)
1. Infections by carbapenemase-producing enterobacteriaceae in a department of urology. A new challenge. Justo-Quintas J; Medina-Polo J; Gil-Moradillo J; Jaén-Herreros F; Lara-Isla A; Tejido-Sánchez Á Actas Urol Esp (Engl Ed); 2018 Apr; 42(3):170-175. PubMed ID: 29157781 [TBL] [Abstract][Full Text] [Related]
2. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study. Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746 [TBL] [Abstract][Full Text] [Related]
3. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis. Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051 [TBL] [Abstract][Full Text] [Related]
4. Surgical site infection by carbapenemase-producing Enterobacteriaceae. A challenge for today's surgeons. Mora-Guzmán I; Rubio-Perez I; Maqueda González R; Domingo Garcia D; Martín-Pérez E Cir Esp (Engl Ed); 2020; 98(6):342-349. PubMed ID: 31980150 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study. Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J; Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368 [TBL] [Abstract][Full Text] [Related]
8. Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections. Smolders D; Hendriks B; Rogiers P; Mul M; Gordts B J Hosp Infect; 2019 May; 102(1):82-88. PubMed ID: 30579969 [TBL] [Abstract][Full Text] [Related]
9. Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting. Pople D; Kypraios T; Donker T; Stoesser N; Seale AC; George R; Dodgson A; Freeman R; Hope R; Walker AS; Hopkins S; Robotham J BMC Med; 2023 Dec; 21(1):492. PubMed ID: 38087343 [TBL] [Abstract][Full Text] [Related]
11. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience. Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity. Castagnola E; Tatarelli P; Mesini A; Baldelli I; La Masa D; Biassoni R; Bandettini R J Infect Public Health; 2019; 12(2):270-274. PubMed ID: 30477920 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study. Maseda E; Salgado P; Anillo V; Ruiz-Carrascoso G; Gómez-Gil R; Martín-Funke C; Gimenez MJ; Granizo JJ; Aguilar L; Gilsanz F Enferm Infecc Microbiol Clin; 2017; 35(6):333-337. PubMed ID: 27016135 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for the development of infections associated with carbapenemase-producing Jimenez A; Fennie K; Munoz-Price LS; Ibrahimou B; Abbo LM; Martinez O; Sposato K; Doi Y; Trepka MJ Infect Control Hosp Epidemiol; 2021 Jun; 42(6):763-766. PubMed ID: 33213537 [TBL] [Abstract][Full Text] [Related]
15. A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment. Cheng VC; Chen JH; So SY; Wong SC; Chau PH; Wong LM; Ching RH; Ng MM; Lee WM; Hung IF; Ho PL; Yuen KY Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1418-1425. PubMed ID: 27619653 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013). Daroukh A; Delaunay C; Bigot S; Ceci JM; Siddhoun N; Bukreyeva I; Raisin J; Porcheret H; Maisonneuve L; Bouldouyre MA Med Mal Infect; 2014 Jul; 44(7):321-6. PubMed ID: 25022890 [TBL] [Abstract][Full Text] [Related]
17. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Giannella M; Bartoletti M; Campoli C; Rinaldi M; Coladonato S; Pascale R; Tedeschi S; Ambretti S; Cristini F; Tumietto F; Siniscalchi A; Bertuzzo V; Morelli MC; Cescon M; Pinna AD; Lewis R; Viale P Clin Microbiol Infect; 2019 Dec; 25(12):1525-1531. PubMed ID: 31039445 [TBL] [Abstract][Full Text] [Related]
19. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization. Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962 [TBL] [Abstract][Full Text] [Related]
20. Validation of the Giannella Risk Score for the Prediction of Infection by Carbapenemase-producing Enterobacteriaceae in the Pediatric Population. Garazzino S; Balletto E; Licciardi F; Denina M; Carraro F; Contino A; Palmero C; Ugolotti E; Silvestro E; Castagnola E Pediatr Infect Dis J; 2022 Feb; 41(2):112-116. PubMed ID: 34471081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]